This inventor holds 1 USPTO granted patent. Top assignee: Thallion Pharmaceuticals Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Nargis Ismail: Innovator in Pharmaceutical Chemistry
Introduction
Nargis Ismail is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that may inhibit tumor cell growth. Her innovative work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Nargis Ismail holds a patent for "Polyene oxazoles and processes for their preparation." This patent describes polyene oxazoles of a specific formula, where R is selected from hydrogen and methyl. These compounds, along with their pharmaceutically acceptable salts, are designed for use in inhibiting tumor cell growth. The polyene oxazoles can be formulated into pharmaceutical compositions with acceptable carriers, making them viable candidates for cancer therapies. The compounds may be derived from specific strains, such as strain 022, which has a deposit number of IDAC 270504-04.
Career Highlights
Nargis Ismail is associated with Thallion Pharmaceuticals Inc., where she continues to advance her research and development efforts. Her work at the company reflects her commitment to innovation in the pharmaceutical industry.
Collaborations
Nargis has collaborated with notable colleagues, including James B McAlpine and Brian O Bachmann. These partnerships have likely contributed to her success and the advancement of her research initiatives.
Conclusion
Nargis Ismail is a trailblazer in the field of pharmaceutical chemistry, with a focus on developing innovative solutions for cancer treatment. Her patent on polyene oxazoles showcases her dedication to improving healthcare through scientific research.